BORNAPRINE HYDROCHLORIDE

Details

Stereochemistry	EPIMERIC
Molecular Formula	C21H31NO2.ClH
Molecular Weight	365.937
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CCN(CC)CCCOC(=O)C1(C[C@@H]2CC[C@H]1C2)C3=CC=CC=C3

InChI

InChIKey=ODVPRPWQGNOPAY-PWITVKHSSA-N

InChI=1S/C21H31NO2.ClH/c1-3-22(4-2)13-8-14-24-20(23)21(18-9-6-5-7-10-18)16-17-11-12-19(21)15-17;/h5-7,9-10,17,19H,3-4,8,11-16H2,1-2H3;1H/t17-,19+,21?;/m1./s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2057518 | https://www.ncbi.nlm.nih.gov/pubmed/7945741 | https://www.ncbi.nlm.nih.gov/pubmed/3514543 | https://www.ncbi.nlm.nih.gov/pubmed/3320624

Bornaptine is a synthetic anticholinergic drug. The compound is a nonselective M1 and M4 antagonist and was shown to inhibit the negative inotropic response to carbachol in the isolated left atrium of the rat with pA2 of 7.27. Bornaprine is used for the treatment of symptoms of Parkinson's disease. A clinical trial showed the superiority of Bornaprine over placebo in reducing parkinsonian tremor. Bornaptine demonstrated positive results in localized hyperhidrosis.

Approval Year

PubMed

Title	Date	PubMed
Hyperhidrosis treatment with bornaprine in the acute phase of spinal cord-injured patients.	2008-08	18332889
Anticholinergics for symptomatic management of Parkinson's disease.	2003	12804486
[Rhabdomyolysis as a complication of Parkinson's disease].	2002-08-08	12165940

Name

Type

Language

3-DIETHYLAMINOPROPYL 2-PHENYLBICYCLO(2.2.1)HEPTANE-2-CARBOXYLATE HYDROCHLORIDE

Preferred Name

English

BORNAPRINE HYDROCHLORIDE

Common Name

English

BORNAPRINE HYDROCHLORIDE [MART.]

Common Name

English

Bornaprine hydrochloride [WHO-DD]

Common Name

English

BORNAPRINE HCL

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID70949699